Breaking Research News from sources other than Breastcancer.org
Comments
-
Paucity of non-oncology specialist visits mediated 23%-57% of excess mortality risk
Wait, does this mean that since they were not properly treated for other issues they died from those things instead of from cancer, and that's why their risk was mitigated??
For-profit medicine is killing us
-
Salamandra: yeah... Upon reviewing the article, I think the take away is "it is better to be rich and healthy than to be sick and poor" which was one of my grandfather's favorite "philosogisms." I think that lack of access to care is killing plenty of people. Much of the state of health care is mind-boggling. I read these reports of how life expectancy has not improved in decades... with a slight exception for herceptin... it's demoralizing... but then I think that there is no doubt in my mind - and plenty of clinical evidence - that available meds have kept me alive longer and with better QOL... so is there something killing off others faster so that they are offsetting my gains? The improved screening which started in the late 20th century was supposed to improve outcomes. So how the heck did unimproved outcomes happen and what can we do about it?
And then there is the problem of for-profit medicine. I'm not sure.... is it killing us or "just" making us bankrupt (literally... and figuratively)? And does that really help anyone? This one we definitely need to do something about.
-
Lumpie I think many bad health practices are on the rise, and so is childhood trauma-- things like this make for worse health outcomes society-wide, offsetting other gains. There is so much more obesity, depression, and anxiety than when I was a kid. Mental health struggles impact physical health a lot -- from the surging cortisol itself to the poorer self care practices which depressed people can have.
-
santabarbarian: Too true. Sadly, many aspects of health seem to have deteriorated. It is interesting, or perhaps I should say telling, that as we see financial security and aspects of the social fabric, including kinship ties, deteriorate, we see a deterioration of physical health. Of course, there is a greater recognition and acknowledgement of mental health challenges today than there was in the past but we can't ignore that our (post?) modern society does seem to have a troubling effect on mental health.
-
Just processing the speed, the change in a 24/7 news day is far more stressful mentally than a cave-human would ever be expected to deal with. The way stress responses are supposed to work is a cortisol surge that then drops away when you are safe. the kids of dangers and stresses we have now do not RESOLVE and so that becomes a toxic level of stress.
We have a "grandmother effect" -- human menopause is evidence that nature wanted more hands on deck to care for babies. So, lost kinship ties WOULD likely have a negative impact on child health.
-
PS read Dr Bruce Perry on tribal man. In a hunter gatherer tribe you'd have about 40 people, all of whom you knew INTIMATELY. If you were a baby you'd never be put down but rather carried by mom or elder sibling.... There would be a ratio of 4 adults to every kid under 6. So there was much better adult modeling/ time spent with adults and a more body-contact kind of upbringing. I can imagine a lot of anxiety is alleviated by the presence of trusted adults all the time.
-
May favorite prof in college taught Anthropology, so I took lots of anthro. We covered a South American indigenous tribe for a good year. (Thanks for the trip down memory lane.) Then I did a lot of maternal-child nursing. So I get the spaced pregnancies and kinship groups from both perspectives. (We clearly need more hands on deck!) And you are right: the intentionally anxiety-producing, relentless news cycles do nothing for our health!
-
I like the grandmother effect explained. It corresponds with what I read about native Americans culture with sisters, aunts, mothers and grandmothers. So many kids move away, have 2 income households and are in daycare, before care, after care. It's often good quality care but it's still not the same family they are around nights, weekends, ,etc. It's also reassuring that menopause is not natures way of saying "you've served your purpose - be gone".
-
Indeed, I think of it more like: "Hey you, with the experience and skills and patience: you are needed to help launch a baby!"
-
Interesting chat. Takes a village to raise a child
-
Interesting article on chemotherapy causing an immune suppression and the risk of ARDS which is what normally causes death in Covid19 patients. Actually, if I'm reading this correctly, it's good news for the immune suppressed group.
-
Jessie, this is fascinating and surely counter-intuitive! I read the article, and this could be my husband and I, though we're in our 70s rather than 60s. I was on fulvestrant and abemaciclib (Ibrance and Faslodex) for 23 mo before being switched to Xeloda. My husband and I have assumed that I am the more at risk of the two of us, but based on this article, it may be the reverse. The "cytokine storm" affect, which appears to be the cause of death in many Covid-19 cases, is lessened in this example because the woman is immunosuppressed whereas her husband is not, and it is he who suffers its affects. Thank you for posting this. I have sent it to my infectious disease professor/guru for his perusal!
-
The 10th Annual National Conference on Work & Cancer has gone virtual! This free, full-day online conference is open to patients, survivors, caregivers, healthcare/HR professionals* and anyone else touched by cancer. Stay tuned for the finalized agenda.
Cancer and Careers
Friday, June 19, 2020
8:45 AM - 5:00 PM Eastern TimeThe 10th-year anniversary of our National Conference on Work & Cancer will be held virtually on Friday, June 19, 2020!
This free, online daylong conference explores the complexities of balancing treatment and recovery with employment and is open to patients, survivors, caregivers, healthcare professionals, employers/HR professionals and anyone else touched by cancer.
Complimentary CEUs/PDCs are available for nurses, social workers and HR professionals. For more information on accreditation, click here.
Note: This event was previously scheduled to be held at the CUNY Graduate Center in NYC. Due to COVID-19, the National Conference will be hosted virtually instead.
Date:
Friday, June 19, 2020
Time:
8:45 AM-5:00 PM
Please log/dial in 10-15 minutes priorLocation:
Online
Webinar & phone options available
Login and dial-in info will be emailed to registrantshttps://www.cancerandcareers.org/en/community/even...
-
Joy -- I know --- it really is good news for those who are immunosuppressed. I have been thinking a lot about the people in that category and the people going through treatment now. I was hoping this article would relieve some of the additional stress. So glad it helped you -- will you let us know what your infectious disease professor says? I know two young people who have had ARDS -- one from the flu and the other from pancreatitis. Both were young with very strong immune systems.
-
I'm walking with the guru's wife this AM and will find out what he had to say. He's busy doing webinars almost every day on the coronavirus.
-
FDA approves pill for aggressive breast cancer that's spread in the body
Another article re Tucatinib. Easy to read. Includes OS and cost numbers.
-
Staying at One's Job to Maintain Employer-Based Health Insurance Among Cancer Survivors and Their Spouses/Partners
Many cancer survivors experience challenges related to employment, including limitations in ability to work. Given that most health insurance coverage for working-age individuals in the US is employer-based, a challenge is the inability to freely leave a job given limitations on health insurance portability, also called job lock. Job lock can negatively affect career trajectory and quality of life. Likewise, spouse/partner job lock can also affect family well-being. We examined job lock prevalence among cancer survivors and their spouses/partners and associated factors in the US.In this study, approximately 1 in 3 cancer survivors in the US reported job lock for themselves or their spouses/partners, suggesting that job lock is common and has implications for the well-being and careers of both survivors and their families. Given higher prevalence of job lock among younger survivors and those with incomes near the poverty level, it is important to note that those earning between 138% and 400% of the FPL are ineligible for Medicaid and may have fewer employment alternatives with comprehensive health benefits. Clinicians, social workers, and navigators have opportunities to identify job lock and other employment concerns throughout treatment/survivorship care and connect survivors with employment and health insurance counseling.Kent EE, de Moor JS, Zhao J, Ekwueme DU, Han X, Yabroff KR. Staying at One's Job to Maintain Employer-Based Health Insurance Among Cancer Survivors and Their Spouses/Partners. JAMA Oncol. Published online April 23, 2020. doi:10.1001/jamaoncol.2020.0742 -
Fight or Flight: Does Stress Make Radiation Therapy Less Effective?
— Suppressing beta-receptor signaling enhanced tumor control in preclinical study
-
mysticalcity - that is fascinating. So possibly the women who experience the most stress from the process of radiation also get the least benefit. ARGH but also so glad they are studying this.
-
Triple negative breast cancer might not actually be 'breast cancer'
....Researchers have discovered...that the molecular mechanisms involved are more closely related to non-breast cancers, and two specific gene mutations may be responsible for the tumor development.
The research team found the presence of a mutated p53 (a tumor suppressor gene whose mutation often leads to cancer development) and a mutated PARP (a gene that maintains DNA integrity) in a large majority of patients with triple negative breast cancer. Specifically, they found that p53 would interact with replicating DNA and PARP, driving cell growth and division.
"Our new findings suggest that the presence of both [p53] and PARP could serve as a good identifier of breast cancers that would respond to combined treatment with talazoparib — a PARP inhibitor that was developed to treat breast cancers with the BRCA mutation — and temozolomide — a chemotherapy agent that is used to treat some brain cancers," said Professor Jill Bargonetti, whose lab conducted the research. "This is an exciting finding because it could lead to the first targeted therapy for triple negative breast cancer, enabling more precise and effective treatment of a very aggressive form of the disease."
...this group plans to test if this combination of drugs can successfully block replication of triple negative breast cancer cells in xenographed animal models. If the therapy can prove to be successful, it would very likely lead to the reclassification of triple negative breast cancer to a category of cancers called mutant p53/PARP1 positive cancers, which are treatable with a combination PARP inhibitor therapies.
This study gives doctors two new biomarkers to test for in patients, and many new potentials in clinical trials, which can be fast tracked since so many drugs already exist that target these specific genes. While this study only tested out two drugs, there are many other drugs that specifically target p53 and PARP, and many more which can be developed, which may give even better results. Hopefully, there will be many new, positive developments for this disease following this discovery.
https://www.clinicalomics.com/topics/precision-med...
https://cancerres.aacrjournals.org/content/early/2...
DOI: 10.1158/0008-5472.CAN-19-1036
-
that's very exciting news
-
It is exciting. And p53 and PARP mutations are pretty common among other types of breast cancer. So maybe the research may lead to new tools for treating other sub-types, too.
-
A couple of days ago I stumbled on a piece of research that might have been linked here before, as it came out in July 2019. But I hadn't seen it and thought it was exciting news about recurrence risk for TNBC. TNBC has a relatively high recurrence risk (in the past week I've seen research numbers such as 22%, 25%, and 42%, so who knows what the real figure is. Regardless, it's high.) Since we don't know which patients will recur and which won't, almost all of them go through the whole range of treatment, including chemo. If we could identify the patients least likely to recur, they could perhaps be spared some of the more aggressive treatment. Here is the abstract and link.
"Approximately 40% of patients with stage I–III triple-negative breast cancer (TNBC) recur after standard treatment, whereas the remaining 60% experience long-term disease-free survival (DFS). There are currently no clinical tests to assess the risk of recurrence in TNBC patients. We previously determined that TNBC patients with MHC class II (MHCII) pathway expression in their tumors experienced significantly longer DFS. To translate this discovery into a clinical test, we developed an MHCII Immune Activation assay, which measures expression of 36 genes using NanoString technology. Preanalytical testing confirmed that the assay is accurate and reproducible in formalin-fixed paraffin-embedded (FFPE) tumor specimens. The assay measurements were concordant with RNA-seq, MHCII protein expression, and tumor-infiltrating lymphocyte counts. In a training set of 44 primary TNBC tumors, the MHCII Immune Activation Score was significantly associated with longer DFS (HR = 0.17; P = 0.015). In an independent validation cohort of 56 primary FFPE TNBC tumors, the Immune Activation Score was significantly associated with longer DFS (HR = 0.19; P = 0.011) independent of clinical stage. An Immune Activation Score threshold for identifying patients with very low risk of relapse in the training set provided 100% specificity in the validation cohort. The assay format enables adoption as a standardized clinical prognostic test for identifying TNBC patients with a low risk of recurrence. Correlative data support future studies to determine if the assay can identify patients in whom chemotherapy can be safely deescalated and patients likely to respond to immunotherapy.
Significance: The MHCII Immune Activation assay identifies TNBC patients with a low risk of recurrence, addressing a critical need for prognostic biomarker tests that enable precision medicine for TNBC patients."
-
Adjuvant Chemotherapy Associated With Early, But Not Sustained, Cognitive Impairment in Women With Early-Stage Breast Cancer
he
addition of chemotherapy to endocrine therapy in the treatment of early-stage
hormone receptor-positive, HER2-negative breast cancer was associated with a
significant increase in the level of perceived cognitive impairment, according
to results of the TAILORx trial published in the Journal of Clinical Oncology.At the 3-month assessment, 36.7% and 26.3% of
patients treated with and without chemotherapy vs no reported cognitive
impairment. While a
significant difference in patient-reported cognitive impairment was also
observed when these respective groups were compared at 6 months, it was no longer seen at 12
months and beyond....neither patient age nor menopausal status was associated with changes in perceived cognitive impairment.
https://www.oncologynurseadvisor.com/home/cancer-t...
Wagner LI, Gray RJ, Sparano JA, et al. Patient-reported cognitive impairment among women with early breast cancer randomly assigned to endocrine therapy alone versus chemoendocrine therapy: results from TAILORx [published April 9, 2020]. J Clin Oncol. doi: 10.1200/JCO.19.01866
-
cfDNA Test May Detect Disease Among Patients Who Are Suspected of Having Cancer
A plasma cfDNA test was able to detect cancer in patients who had a high suspicion of cancer, and was able to predict tissue of origin among patients with confirmed cancer, according to results presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting I 2020.
In the overall substudy 2 cohort, the cfDNA test had 99.8% and 99.3% specificity for detecting cancer in training and validation, respectively. In the HCS subgroup from substudy 2, the specificity increased to 100% for both training and validation.
https://www.cancertherapyadvisor.com/home/cancer-t...
Thiel DD, Chen X, Kurtzman KN, et al. Prediction of cancer and tissue of origin in individuals with suspicion of cancer using a cell-free DNA multi-cancer early detection test. Presented at: American Association for Cancer Research (AACR) Virtual Annual Meeting I; April 27-28, 2020. Abstract CT021.
-
Meet My Loved One: Making palliative connections in times of isolation
...she wrote down all the little personal details she would have told the nurses and staff as if she were there in person. The fact that he liked to watch "Animal Planet." His love of ice cream, and his distaste for rice. His preference for cold drinks that felt better when he swallowed. And that no one needed to make him wear his oxygen if the canula made him uncomfortable. She emailed it to her dad's social worker and asked that it be taped on the wall.
The effort, and the health care team's response, brought her some peace of mind.
"It's the little things that mean so much," {his daughter} Harding said.
https://www.uab.edu/medicine/palliativecare/patient-care/covid-19-resources
{Not therapeutic research but I thought this might be helpful to someone.}
-
Congress must tackle patient matching amid COVID-19, says Pew Charitable Trusts
Persistent flaws in the ability to accurately ID and match patient records are hindering two must-haves on the road to reopening: contact tracing and, eventually, vaccine administration.
Detailed contact tracing in the short term and a nationwide vaccination program in the long term "hinge on having correct patient demographic data," according to the letter, but "current flaws in the identification and matching of patient records inhibit the nation's ability to accomplish these efforts successfully."
The need for better patient matching is a drum that Pew has been beating for a long time....
{An interesting is slightly wonky, discussion of a current public health issue.}
-
Lumpie - love the article about the Dad in palliative care and what his daughter wrote to post by his bedside. Great ideas. Something we should all pay attention to even when there is no virus.
-
Killing 'sleeper cells' may enhance breast cancer therapy
The research, which used breast cancer cells taken from patients, was the first to show that venetoclax could kill sleeping, or "senescent," cancer cells.
The promising preclinical results for this "triple therapy" have underpinned a phase 1 clinical trial in Melbourne that is combining venetoclax with hormone therapy and CDK4/6 inhibitors in patients with ER+ breast cancer.
https://medicalxpress.com/news/2020-05-sleeper-cells-breast-cancer-therapy.html
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team